Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease
Clinical Kidney Journal Feb 11, 2018
Gillis K, et al. - This current investigation for the impact of ascorbic acid on oxidative stress and vascular function in chronic kidney disease (CKD) patients compared with controls with hypertension (HTN) demonstrated pro- and antioxidant effects of ascorbic acid, resulting in an attenuation in central blood pressure and augmentation index in HTN and CKD. Moreover, via attenuating serum asymmetric dimethylarginine (ADMA) in CKD, ascorbic acid may offer longer-term benefits.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries